HER2/CEP17 ratio predicts residual cancer burden after neoadjuvant dual HER2 blockade: real-world data in patients with primary HER2-amplified breast cancer.

Saved in:
Bibliographic Details
Title: HER2/CEP17 ratio predicts residual cancer burden after neoadjuvant dual HER2 blockade: real-world data in patients with primary HER2-amplified breast cancer.
Authors: Stolz M; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Farr A; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Tendl-Schulz KA; Department of Pathology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Frommlet F; Institute of Medical Statistics, Informatics and Intelligent Systems (CeMSIIS), Medical University of Vienna, Vienna, Austria., Reckendorfer H; Institute of Clinical Pathology, Cytology and Microbiology Ltd. Vienna, Dr. Kosak Und Partner - Fachärzte Für Pathologie GmbH, Vienna, Austria., Koperek O; Laboratory Kaserer, Koperek and Beer Ltd., Vienna, Austria., Neudert B; Department of Pathology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Marhold M; Department of Medicine I, Division of Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Heber U; Department of Pathology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Exner R; Department of General and Visceral Surgery, Division of Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Singer CF; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Bartsch R; Department of Medicine I, Division of Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Bago-Horvath Z; Department of Pathology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. zsuzsanna.horvath@meduniwien.ac.at.
Source: Virchows Archiv : an international journal of pathology [Virchows Arch] 2025 Nov; Vol. 487 (5), pp. 1015-1024. Date of Electronic Publication: 2025 Aug 05.
Publication Type: Journal Article
Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 9423843 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2307 (Electronic) Linking ISSN: 09456317 NLM ISO Abbreviation: Virchows Arch Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-2307
DOI:10.1007/s00428-025-04203-5